Actoplus Met - pioglitazone and metformin hydrochloride
Navigation: NDC > Supplier starting with: T > TAKEDA PHARMACEUTICALS AMERICA, INC.| Field | Value |
|---|---|
| NDC Code: | 64764-510 |
| Proprietary Name: | Actoplus Met |
| Suffix: | XR |
| Non-Proprietary Name: | pioglitazone and metformin hydrochloride |
| Dosage Form: | TABLET, FILM COATED, EXTENDED RELEASE |
| Method: | ORAL |
| Original Marketing Date: | 11-06-2010 |
| Category Name: | NDA |
| Application Number: | NDA022024 |
| Labeler: | TAKEDA PHARMACEUTICALS AMERICA, INC. |
| Substance Name: | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
| Active Numerator Strength: | 1000; 15 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |
| DEA Schedule: |